Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552623 | SCV000651652 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2024-10-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001568025 | SCV001791816 | likely benign | not provided | 2019-11-21 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26392352, 26901136) |
Ambry Genetics | RCV002341430 | SCV002642497 | likely benign | Inborn genetic diseases | 2020-02-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001568025 | SCV004811170 | uncertain significance | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | DYNC1H1: PP2, BS1:Supporting |
Mayo Clinic Laboratories, |
RCV001568025 | SCV005409820 | uncertain significance | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing | BS2, PP2 |